Despite this, there was no significant change in the inflammatory biomarker CRP, or the inflammatory cytokines IL-6 or TNFα, in agreement with other vitamin C/antioxidant intervention studies in obesity and diabetes [21,22]. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.